Molecule Structure

Scientific Name

Edoxaban

Description of the Drug

Edoxaban is a novel oral anticoagulant used for reducing the risk of stroke and systemic embolism (SE) in patients with nonvalvular atrial fibrillation (NVAF).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB09075

Brand Name(s)

Lixiana

Company Owner(s)

Daiichi Sankyo Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Coagulation factor X SINGLE PROTEIN INHIBITOR CHEMBL244

Unichem Links

SureChEMBL SCHEMBL330046
PharmGKB PA166128806
DrugBank DB09075
PubChem: Thomson Pharma 15285745
PubChem 10280735
Nikkaji J2.812.474K
BindingDB 50328731
EPA CompTox Dashboard DTXSID50197398
DrugCentral 4897
Brenda 43553 40399 77414
ChemicalBook CB32593620 CB21518508
Guide to Pharmacology 7575
GSRS 8af0cc62-b5e1-4861-ac09-86e83e7102dd
rxnorm SAVAYSA EDOXABAN TOSYLATE EDOXABAN
ChEBI 85973
ZINC ZINC000043200832